BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29288564)

  • 1. Luteinizing hormone and insulin resistance in menopausal patients with adrenal incidentalomas: The cause-effect relationship?
    Marina LV; Ivović M; Tančić-Gajić M; Arizanović Z; Raković D; Milin-Lazović J; Kendereški A; Micić D; Vujović S
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):541-548. PubMed ID: 29288564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications.
    Ivović M; Marina LV; Vujović S; Tančić-Gajić M; Stojanović M; Radonjić NV; Gajić M; Soldatović I; Micić D
    Metabolism; 2013 Jun; 62(6):786-92. PubMed ID: 23332445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?
    Muscogiuri G; Sorice GP; Prioletta A; Mezza T; Cipolla C; Salomone E; Giaccari A; Pontecorvi A; Della Casa S
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):300-5. PubMed ID: 21070314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
    Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels.
    Yener S; Comlekci A; Akinci B; Secil M; Demir T; Ertilav S; Yesil S
    J Endocrinol Invest; 2009 Apr; 32(4):338-43. PubMed ID: 19636203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
    Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adrenal gland may be a target of LH action in postmenopausal women.
    Alevizaki M; Saltiki K; Mantzou E; Anastasiou E; Huhtaniemi I
    Eur J Endocrinol; 2006 Jun; 154(6):875-81. PubMed ID: 16728548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
    Belokovskaya R; Ravikumar A; Arumugam D; Izadmehr S; Goddard GM; Geer EB; Levine AC
    Endocr Pract; 2019 Aug; 25(8):846-853. PubMed ID: 31070948
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance.
    Arduc A; Isik S; Ozuguz U; Tutuncu YA; Kucukler FK; Ozcan HN; Berker D; Guler S
    Endocr Res; 2014; 39(3):99-104. PubMed ID: 24152247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion.
    Šojat AS; Dunjić-Kostić B; Marina LV; Ivović M; Radonjić NV; Kendereški A; Ćirković A; Tančić-Gajić M; Arizanović Z; Mihajlović S; Vujović S
    J Endocrinol Invest; 2021 Sep; 44(9):1935-1945. PubMed ID: 33528757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
    Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.
    Debono M; Chadarevian R; Eastell R; Ross RJ; Newell-Price J
    PLoS One; 2013; 8(4):e60984. PubMed ID: 23577182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
    Olsen H; Olofsson L; Mjöman M
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
    Debono M; Harrison RF; Chadarevian R; Gueroult C; Abitbol JL; Newell-Price J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3461-3469. PubMed ID: 28911138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.